Aortoiliac steno-occlusive arterial disease with ischaemic pain at rest or when walking (claudication) or tissue loss (gangrene) Circulatory System Claudication, gangrene
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Infrarenal chronic aorto-iliac occlusive/stenotic symptomatic disease for >14 Days 2. Treatment by an aortic stent graft or bare metal stent with or without iliac stenting
Exclusion criteria
Exclusion criteria: 1. Acute aortic occlusive disease 2. Aneurysm related interventions 3. Previous aorto-iliac stenting or In-Stent-Restenosis 4. Aortic coarctation 5. Isolated Kissing-Stent-Reconstruction without aortic stents 6. Aortic injury/trauma related interventions 7. Suprarenal/visceral segment reconstructions
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Re-intervention-free-survival, defined as the composite endpoint of target lesion revascularization (TLR) and/or death, whichever occurred first, obtained from clinician notes collected at day of discharge from hospital, 30 days after the procedure, and latest available follow-up. | — |
Secondary
| Measure | Time frame |
|---|---|
| The following outcome measures will be obtained from clinician notes, collected at day of discharge from hospital, 30 days after the procedure, and latest available follow-up 1. Acute technical success 2. 30-days morbidity 3. 30-days mortality 4. Overall mortality 5. Conversion-to-surgery free time 6. Re-intervention free time | — |
Countries
Belgium, France, Germany, Greece, Italy, Netherlands, Spain, United Kingdom